NKG2C deletion is a risk factor for human cytomegalovirus viremia and disease after lung transplantation

27Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Human cytomegalovirus (HCMV) replication is limited by HCMV-specific natural killer (NK) cell response. Distinct genetic polymorphisms, which are potentially involved in antiviral NK cell response, have been described. Here, the association between polymorphisms at IgG1 genetic marker 3/17, FcγRIIIα/ CD16a 158V/F, NKG2C wt/del , CD226/rs727088, and rs763361, respectively, and HCMV viremia and disease were investigated in 98 lung transplant recipients (LTRs), within 9 months after stop of posttransplant HCMV prophylaxis. From all variants, only the NKG2C wt/wt genotype was significantly associated with freedom from HCMV viremia (P = .0002) and disease (P = .02), compared with the NKG2C wt/del genotype. Thus, LTRs expressing the homozygous NKG2C wild type seem to have a selective advantage in HCMV defense.

Cite

CITATION STYLE

APA

Vietzen, H., Pollak, K., Honsig, C., Jaksch, P., & Puchhammer-Stöckl, E. (2018). NKG2C deletion is a risk factor for human cytomegalovirus viremia and disease after lung transplantation. Journal of Infectious Diseases, 217(5), 802–806. https://doi.org/10.1093/infdis/jix608

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free